A probiotic strain produced by BioGaia (Raleigh, NC) has demonstrated a substantially reduced frequency of regurgitation in infants.
A probiotic strain produced by BioGaia (Raleigh, NC) has demonstrated a substantially reduced frequency of regurgitation in infants, according to research published in the European Journal of Clinical Investigation.
The probiotic specialist announced the news as supporting a previous trial on its Lactobacillus reuteri Protectis strain against uncomplicated infant regurgitation.
In the double-blind, placebo-controlled study, 42 formula-fed infants under four months of age were assigned to daily supplementation of placebo or the probiotic for 30 days. Incidence of regurgitate was reduced by 80% in the probiotic group compared to 33% in the placebo group. During the final week, regurgitation was reduced by an average 75% with probiotic compared to placebo.
“Uncomplicated regurgitation is common among infants and we are convinced that these exciting results with L. reuteri will have an impact on future handling of infants with persistent regurgitation,” said study author Flavia Indrio of the University of Bari (Italy) department of pediatrics.
Check out the study’s abtract here.
Driving Sustainability in Nutraceuticals: How Ingredient Brands Are Raising the Bar
April 26th 2024Health-minded consumers, especially Generation Z, value nutraceutical companies with sustainability embedded into their corporate philosophy—from product development to packaging. This article discusses how responsible companies are responding to the consumer call for greater sustainability by implementing environmentally friendly manufacturing practices that ultimately lead to waste reduction, improved supplier communications and lower supply chain risk. Those who have taken steps to demonstrate a genuine commitment to sustainability are standing out with improved outcomes for all.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.